Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Antal

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 1986
Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combinationG L Drusano, R J Townsend, T J Walsh, et al.
Journal of Clinical Psychopharmacology|September 16, 2006
Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signsE H Uhlenhuth, Vladan Starcevic, Clifford Qualls, et al.
Depression and Anxiety|October 27, 2007
Cognitive style, alprazolam plasma levels, and treatment response in panic disorderE H Uhlenhuth, Vladan Starcevic, Clifford Qualls, et al.
Clinical Pharmacy|November 1, 1988
Clindamycin pharmacokinetics and tissue penetration after head and neck surgeryG P Stoehr, V L Yu, J T Johnson, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
An evaluation of population pharmacokinetics in therapeutic trials. Part II. Detection of a drug-drug interactionT H Grasela, E J Antal, L Ereshefsky, et al.
Journal of Pharmaceutical Sciences|March 1, 1985
Liquid chromatographic assay for fluoxymesterone in human serum with application to a preliminary bioavailability studyV J Capponi, S R Cox, E L Harrington, et al.
Journal of Clinical Pharmacology|March 1, 1986
The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolitesE J Antal, C E Wright, B L Brown, et al.
Critical Care Medicine|May 1, 1996
Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humansG S Hughes, E J Antal, P K Locker, et al.
Biopharmaceutics & Drug Disposition|July 1, 1985
Theoretical decrease in systemic availability with decrease in input rate at steady-state for first-pass drugsJ G Wagner, E J Antal, A T Elvin, et al.
Journal of Clinical Pharmacology|May 22, 2001
Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramineE J Antal, P E Hendershot, D H Batts, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|July 1, 1986
Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combinationG L Drusano, R J Townsend, T J Walsh, et al.
Journal of Clinical Psychopharmacology|September 16, 2006
Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signsE H Uhlenhuth, Vladan Starcevic, Clifford Qualls, et al.
Depression and Anxiety|October 27, 2007
Cognitive style, alprazolam plasma levels, and treatment response in panic disorderE H Uhlenhuth, Vladan Starcevic, Clifford Qualls, et al.
Clinical Pharmacy|November 1, 1988
Clindamycin pharmacokinetics and tissue penetration after head and neck surgeryG P Stoehr, V L Yu, J T Johnson, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
An evaluation of population pharmacokinetics in therapeutic trials. Part II. Detection of a drug-drug interactionT H Grasela, E J Antal, L Ereshefsky, et al.
Journal of Pharmaceutical Sciences|March 1, 1985
Liquid chromatographic assay for fluoxymesterone in human serum with application to a preliminary bioavailability studyV J Capponi, S R Cox, E L Harrington, et al.
Journal of Clinical Pharmacology|March 1, 1986
The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolitesE J Antal, C E Wright, B L Brown, et al.
Critical Care Medicine|May 1, 1996
Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humansG S Hughes, E J Antal, P K Locker, et al.
Biopharmaceutics & Drug Disposition|July 1, 1985
Theoretical decrease in systemic availability with decrease in input rate at steady-state for first-pass drugsJ G Wagner, E J Antal, A T Elvin, et al.
Journal of Clinical Pharmacology|May 22, 2001
Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramineE J Antal, P E Hendershot, D H Batts, et al.
Pageof 11